Drug-Eluting Stents. Life Insurance With a Better Death Benefit**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 51, Issue 21, 2008, Pages 2025-2027

  Anderson, H Vernon ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METAL;

CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; EDITORIAL; ELDERLY CARE; EVIDENCE BASED MEDICINE; LONG TERM CARE; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; HUMANS; STENTS; TREATMENT OUTCOME;

EID: 43649085526     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.02.053     Document Type: Editorial

References (33)

1. Kelbæk H., Kløvgaard L., Helqvist S., et al. Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) trial. J Am Coll Cardiol 51 (2008) 2011-2016
2. Groeneveld P.W., Matta M.A., Greenhut A.P., and Yang F. Drug-eluting compared with bare-metal coronary stents among elderly patients. J Am Coll Cardiol 51 (2008) 2017-2024
3. Rao S.V., Shaw R.E., Brindis R.G., Klein L.W., Weintraub W.S., and Peterson E.D. On- versus off-label use of drug-eluting coronary stents in clinical practice. Am J Cardiol 97 (2006) 1478-1481
4. Beohar N., Davidson C.J., Kip K.E., et al. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA 297 (2007) 1992-2000
5. Win H.K., Caldera A.E., Maresh K., et al. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 297 (2007) 2001-2009
6. Qasim A., Cosgrave J., Latib A., and Colombo A. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications. Am J Cardiol 100 (2007) 1619-1624
7. Doyle B., Rihal C.S., O'Sullivan C.J., Lennon R.J., Wiste H.J., Bell M., Bresnahan J., and Holmes D.R. Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal stents. Circulation 116 (2007) 2391-2398
8. Marroquin O.C., Selzer F., Mulukutla S.R., et al. A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med 358 (2008) 342-352
9. Kelbaek H., Thuesen L., Helqvist S., et al. The stenting coronary arteries in non-stress/benestent disease (SCANDSTENT) trial. J Am Coll Cardiol 47 (2006) 449-455
10. Schofer J., Schluter M., Gershlick A.H., Wijns W., Garcia E., Schampaert E., and Breithardt G. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomized controlled trial (E-SIRIUS). Lancet 362 (2003) 1093-1099
11. Ardissino D., Cavallini C., Bramucci E., et al. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries. JAMA 292 (2004) 2727-2734
12. Stone G.W., Ellis S.G., Cannon L., et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease. JAMA 294 (2005) 1215-1223
13. Kelbaek H., Helqvist S., Thuesen L., et al. Sirolimus versus bare metal stent implantation in patients with total coronary occlusions. Am Heart J 152 (2006) 882-886
14. Thuesen L., Kelbaek H., Klovgaard L., et al. Comparison of sirolimus-eluting and bare metal stents in coronary bifurcation lesions. Am Heart J 152 (2006) 1140-1145
15. Suttorp M.J., Laarman G.J., Rahel B.M., et al. Primary stenting of totally occluded native coronaries II (PRISON II). Circulation 114 (2006) 921-928
16. Colombo A., Moses J.W., Morice M.C., et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 109 (2004) 1244-1249
17. Ge L., Airoldi F., Iakovou I., et al. Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique. J Am Coll Cardiol 46 (2005) 613-620
18. Morice M.C., Serruys P.W., Barragan P., et al. Long-term clinical outcomes with sirolimus-eluting coronary stents. J Am Coll Cardiol 50 (2007) 1299-1304
19. Taddei C.F.G., Weintraub W.S., Douglas J.S., et al. Influence of age on outcome after percutaneous transluminal coronary angioplasty. Am J Cardiol 84 (1999) 245-251
20. Alexander K.P., Roe M.T., Chen A.Y., et al. Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol 46 (2005) 1479-1487
21. Thompson R.C., Holmes D.R., Grill D.E., Mock M.B., and Bailey K.R. Changing outcome of angioplasty in the elderly. J Am Coll Cardiol 27 (1996) 8-14
22. Lefevre T., Morice M.C., Eltchaninoff H., et al. One-month results of coronary stenting in patients ≥75 years of age. Am J Cardiol 82 (1998) 17-21
23. Chauhan M.S., Kuntz R.E., Ho K.K.L., et al. Coronary artery stenting in the aged. J Am Coll Cardiol 37 (2001) 856-862
24. Munoz J.C., Alonso J.J., Duran J.M., et al. Coronary stent implantation in patients older than 75 years of age: clinical profile and initial and long-term (3 years) outcome. Am Heart J 143 (2002) 620-626
25. Kobayashi Y., Mehran R., Mintz G.S., et al. Comparison of in-hospital and one-year outcomes after multiple coronary arterial stenting in patients ≥80 years old versus those <80 years old. Am J Cardiol 92 (2003) 443-446
26. Pfisterer M. Long-term outcome in elderly patients with chronic angina managed invasively versus optimized medical therapy. Circulation 110 (2004) 1213-1218
27. Clark M.A., Bakhai A., Lacey M.J., Pelletier E.M., and Cohen D.J. Clinical and economic outcomes of percutaneous coronary interventions in the elderly. Circulation 110 (2004) 259-264
28. Vijaykumar M., Lemos P.A., Hoye A., et al. Effectiveness of sirolimus-eluting stent implantation for the treatment of coronary artery disease in octogenarians. Am J Cardiol 94 (2004) 909-913
29. Nordman A.J., Briel M., and Bucher H.C. Mortality in randomized trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J 27 (2006) 2784-2814
30. Stettler C., Wandel S., Allemann S., et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370 (2007) 937-948
31. Tu J.V., Bowen J., Chiu M., et al. Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med 357 (2007) 1393-1402
32. Lagerqvist B., James S.K., Stenestrand U., Lindback J., Nilsson T., and Wallentin L. Long-term outcomes with durg-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356 (2007) 1009-1019
33. Marzocchi A., Saia F., Piovaccari G., et al. Long-term safety and efficacy of drug-eluting stents. Circulation 115 (2007) 3181-3188